Quantinuum has been selected by the Defense Advanced Research Projects Agency (DARPA) to advance to Stage B of the Quantum Benchmarking Initiative (QBI). The initiative is designed to assess the feasibility of achieving a utility-scale quantum computer by 2033.
The selection follows Quantinuum’s completion of Stage A, during which the company developed and delivered a concept design for a system named “Lumos.” According to DARPA’s plan, Stage B will involve a year-long evaluation where Quantinuum will produce a detailed research and development roadmap for Lumos. This stage aims to validate technical assumptions, verification methods, and scaling plans necessary to meet the 2033 objective.
Quantinuum has previously released its public roadmap outlining plans through the end of this decade. The company announced that Apollo, its universal fully fault-tolerant quantum computer, is scheduled for launch in 2029. Lumos extends these plans into the next decade as Quantinuum prepares for larger-scale systems.
Dr. Rajeeb Hazra, President and CEO of Quantinuum, stated: “This selection recognizes the strength and maturity of our roadmap and the work our teams have already delivered. Lumos extends our roadmap into the next decade and gives DARPA a concrete, de-risked path for achieving utility-scale quantum computing by 2033. We look forward to partnering with DARPA and our ecosystem partners to advance this important national objective.”
Recently, Quantinuum deployed its latest generation system called “Helios,” in line with its published schedule. Helios features advanced physical qubits and logical qubits along with an updated software stack that includes a modern high-level programming language. The system has been used in simulations related to high-temperature superconductivity and magnetism at large scales—areas considered significant for industrial applications.
Quantinuum employs over 630 people worldwide—including more than 370 scientists and engineers—across locations in the United States, United Kingdom, Germany, and Japan.
More information about Quantinuum can be found at www.quantinuum.com
